Weinberg RA: Oncogenes and tumor suppressor genes. CA Cancer J Clin. 1994, 44: 160-170.
Article
CAS
PubMed
Google Scholar
Bishop JM: Molecular themes in oncogenesis. Cell. 1991, 64: 235-248. 10.1016/0092-8674(91)90636-D.
Article
CAS
PubMed
Google Scholar
Cooper GM: Oncogenes. 1995, Boston: Jones and Bartlett Publishers
Google Scholar
Crook T, Wrede D, Tidy JA, Mason WP, Evans DJ, Vousden KH: Clonal p53 mutation in primary cervical cancer: association with human-papillomavirus-negative tumours. Lancet. 1992, 339: 1070-1073. 10.1016/0140-6736(92)90662-M.
Article
CAS
PubMed
Google Scholar
Busby-Earle RMC, Steel CM, Williams ARW, Cohen B, Bird CC: p53 mutations in cervical carcinogenesis – low frequency and lack of correlation with human papillomavirus status. Br J Cancer. 1994, 69: 732-737.
Article
CAS
PubMed
PubMed Central
Google Scholar
Topol LZ, Marx M, Laugier D, Bogdanova NN, Boubnov NV, Clausen PA, Calothy G, Blair DG: Identification of drm, a novel gene whose expression is suppressed in transformed cells and which can inhibit growth of normal but not transformed cells in culture. Mol Cell Biol. 1997, 17: 4801-4810.
Article
CAS
PubMed
PubMed Central
Google Scholar
Topol LZ, Bardot B, Zhang Q, Resau J, Huillard E, Marx M, Calothy G, Blair DG: Biosynthesis, post-translation modification, and functional characterization of Drm/Gremlin. J Biol Chem. 2000, 275: 8785-8793. 10.1074/jbc.275.12.8785.
Article
CAS
PubMed
Google Scholar
Pearce JJ, Penny G, Rossant J: A mouse cerberus/Dan-related gene family. Dev Biol. 1999, 209: 98-110. 10.1006/dbio.1999.9240.
Article
CAS
PubMed
Google Scholar
Isaacs NW: Cystine knots. Curr Opin Struct Biol. 1995, 5: 391-395. 10.1016/0959-440X(95)80102-2.
Article
CAS
PubMed
Google Scholar
Capdevila J, Tsukui T, Rodriquez Esteban C, Zappavigna V, Izpisua Belmonte JC: Control of vertebrate limb outgrowth by the proximal factor Meis2 and distal antagonism of BMPs by Gremlin. Mol Cell. 1999, 4: 839-849. 10.1016/S1097-2765(00)80393-7.
Article
CAS
PubMed
Google Scholar
Dionne MS, Skarnes WC, Harland RM: Mutation and analysis of Dan, the founding member of the Dan family of transforming growth factor β antagonists. Mol Cell Biol. 2001, 21: 636-643. 10.1128/MCB.21.2.636-643.2001.
Article
CAS
PubMed
PubMed Central
Google Scholar
Khokha MK, Hsu DR, Brunet LJ, Dionne MS, Harland RM: Gremlin is the BMP antagonist required for maintenance of Shh and Fgf signals during limb patterning. Nat Genet. 2003, 34: 303-307. 10.1038/ng1178.
Article
CAS
PubMed
Google Scholar
Zuniga A, Haramis AP, McMahon AP, Zeller R: Signal relay by BMP antagonism controls the SHH/FGF4 feedback loop in vertebrate limb buds. Nature. 1999, 401: 598-602. 10.1038/44157.
Article
CAS
PubMed
Google Scholar
Chen B, Athanasiou M, Gu Q, Blair DG: Drm/Gremlin transcriptionally activates p21Cip1 via a novel mechanism and inhibits neoplastic transformation. Biochem Biophys Res Commun. 2002, 295: 1135-1141. 10.1016/S0006-291X(02)00828-8.
Article
CAS
PubMed
Google Scholar
Hanaoka E, Ozaki T, Nakamura Y, Moriya H, Nakagawara A, Sakiyama S: Overexpression of Dan causes a growth suppression in p53-deficient SAOS-2 cells. Biochem Biophys Res Commun. 2000, 278: 20-26. 10.1006/bbrc.2000.3758.
Article
CAS
PubMed
Google Scholar
Lappin DW, Hensey C, McMahon R, Godson C, Brady HR: Gremlins, glomeruli and diabetic nephropathy. Curr Opin Nephrol Hypertens. 2000, 9: 469-472. 10.1097/00041552-200009000-00002.
Article
CAS
PubMed
Google Scholar
Michos O, Panman L, Vintersten K, Beier K, Zeller R, Zuniga A: Gremlin-mediated BMP antagonism induces the epithelial-mesenchymal feedback signaling controlling metanephric kidney and limb organogenesis. Development. 2004, 131 (14): 3401-3410. 10.1242/dev.01251.
Article
CAS
PubMed
Google Scholar
Merino R, Rodriguez-Leon J, Macias D, Ganan Y, Economides AN, Hurle JM: The BMP antagonist Gremlin regulates outgrowth,chondrogenesis and programmed cell death in the developing limb. Development. 1999, 126: 5515-5522.
CAS
PubMed
Google Scholar
Hsu DR, Economides AN, Wang X, Eimon PM, Harland RM: The Xenopus dorsalizing factor Gremlin identifies a novel family of secreted proteins that antagonize BMP activities. Mol Cell. 1998, 1: 673-683. 10.1016/S1097-2765(00)80067-2.
Article
CAS
PubMed
Google Scholar
Ichimura T, Isobe T, Okuyama T, Takahashi N, Araki K, Kuwano R, Takahashi Y: Molecular cloning of cDNA coding for brain-specific 14-3-3 protein, a protein kinase-dependent activator of tyrosine and tryptophan hydroxylases. Proc Natl Acad Sci USA. 1988, 85: 7084-7088.
Article
CAS
PubMed
PubMed Central
Google Scholar
Ichimura-Ohshima Y, Morii K, Ichimura T, Araki K, Takahashi Y, Isobe T, Minoshima S, Fukuyama R, Shimizu N, Kuwano R: cDNA cloning and chromosome assignment of the gene for human brain 14-3-3 protein eta chain. J Neurosci Res. 1992, 31: 600-605. 10.1002/jnr.490310403.
Article
CAS
PubMed
Google Scholar
Ichimura T, Uchiyama J, Kunihiro O, Ito M, Horigome T, Omata S, Shinkai F, Kaji H, Isobe T: Identification of the site of interaction of the 14-3-3 protein with phosphorylated tryptophan hydroxylase. J Biol Chem. 1995, 270: 28515-28518. 10.1074/jbc.270.48.28515.
Article
CAS
PubMed
Google Scholar
Tommerup N, Leffers H: Assignment of the human genes encoding 14-3-3 Eta (YWHAH) to 22q12, 14-3-3 zeta (YWHAZ) to 2p25.1-p25.2, and 14-3-3 beta (YWHAB) to 20q13.1 by in situ hybridization. Genomics. 1996, 33: 149-150. 10.1006/geno.1996.0176.
Article
CAS
PubMed
Google Scholar
Vincenz C, Dixit VM: 14-3-3 proteins associate with A20 in an isoform-specific manner and function both as chaperone and adapter molecules. J Biol Chem. 1996, 271: 20029-20034. 10.1074/jbc.271.33.20029.
Article
CAS
PubMed
Google Scholar
Wakui H, Wright AP, Gustafsson J, Zilliacus J: Interaction of the ligand-activated glucocorticoid receptor with the 14-3-3 eta protein. J Biol Chem. 1997, 272: 8153-8156. 10.1074/jbc.272.13.8153.
Article
CAS
PubMed
Google Scholar
Toyooka K, Muratake T, Tanaka T, Igarashi S, Watanabe H, Takeuchi H, Hayashi S, Maeda M, Takahashi M, Tsuji S, Kumanishi T, Takahashi Y: 14-3-3 protein eta chain gene (YWHAH) polymorphism and its genetic association with schizophrenia. Am J Med Genet. 1999, 88: 164-167. 10.1002/(SICI)1096-8628(19990416)88:2<164::AID-AJMG13>3.0.CO;2-3.
Article
CAS
PubMed
Google Scholar
Yu T, Robb VA, Singh V, Gutmann DH, Newsham IF: The 4.1/ezrin/radixin/moesin domain of the DAL-1/Protein 4.1B tumour suppressor interacts with 14-3-3 proteins. Biochem J. 2002, 365 (PT 3): 783-789.
Article
CAS
PubMed
PubMed Central
Google Scholar
Sato S, Fujita N, Tsuruo T: Regulation of kinase activity of 3-phosphoinositide-dependent protein kinase-1 by binding to 14-3-3. J Biol Chem. 2002, 277: 39360-39367. 10.1074/jbc.M205141200.
Article
CAS
PubMed
Google Scholar
Kim JW, Lee CG, Cho YH, Kim JH, Kim SJ, Kim HK, Park TC, Song SK, Namkoong SE: CUMC-6, a new diploid human cell line derived from a squamous carcinoma of the uterine cervix. Gynecol Oncol. 1996, 62: 230-240. 10.1006/gyno.1996.0221.
Article
CAS
PubMed
Google Scholar
Liang P, Pardee AB: Differential display of eukaryotic messenger RNA by means of the polymerase chain reaction. Science. 1992, 257: 967-971.
Article
CAS
PubMed
Google Scholar
Opitz OG: Telomeres, telomerase and malignant transformation. Curr Mol Med. 2005, 5 (2): 219-226. 10.2174/1566524053586626.
Article
CAS
PubMed
Google Scholar
Wai LK: Telomeres, telomerase, and tumorigenesis-a review. MedGenMed. 2004, 6 (3): 19-
PubMed
PubMed Central
Google Scholar
Topol LZ, Modi WS, Koochekpour S, Blair DG: Drm/Gremlin maps to human chromosome 15 and is highly expressed in adult and fetal brain. Cytogenet Cell Genet. 2000, 89: 79-84. 10.1159/000015568.
Article
CAS
PubMed
Google Scholar
Wick W, Petersen I, Schmutzler RK, Wolfarth B, Lenartz D, Bierhoff E, Hummerich JI, Muller DJ, Stangl AP, Schramm J, Wiestler OD, von Deimling A: Evidence for a novel tumor suppressor gene on chromosome15 associated with progression to a metastatic stage in breast cancer. Oncogene. 1996, 12: 973-978.
CAS
PubMed
Google Scholar
Chen B, Blair DG, Plisov S, Vasiliev G, Perantoni AO, Chen Q, Athanasiou M, Wu JY, Oppenheim JJ, Yang D: Cutting edge: bone morphogenetic protein antagonists Drm/Gremlin and Dan interact with Slits and act as negative regulators of monocyte chemotaxis. J Immunol. 2004, 173: 5914-5917.
Article
CAS
PubMed
Google Scholar
Suzuki M, Shigematsu H, Shames DS, Sunaga N, Takahashi T, Shivapurkar N, Iizasa T, Frenkel EP, Minna JD, Fujisawa T, Gazdar AF: DNA methylation-associated inactivation of TGFbeta-related genes DRM/Gremlin,RUNX3, and HPP1 in human cancers. Br J Cancer. 2005, 93: 1029-1037. 10.1038/sj.bjc.6602837.
Article
CAS
PubMed
PubMed Central
Google Scholar
Fu H, Subramanian RR, Masters SC: 14- 3-3 PROTEINS: Structure, function, and regulation. Annu Rev Pharmacol Toxicol. 2000, 40: 617-647. 10.1146/annurev.pharmtox.40.1.617.
Article
CAS
PubMed
Google Scholar
Fanger GR, Widmann C, Porter AC, Sather S, Johnson GL, Vaillancourt RR: 14-3-3 proteins interact with specific MEK kinases. J Biol Chem. 1998, 273: 3476-3483. 10.1074/jbc.273.6.3476.
Article
CAS
PubMed
Google Scholar
Craparo A, Freund R, Gustafson TA: 14- 3-3 interacts with the insulin-like growth factor I receptor and insulin receptor substrate I in a phosphoserine-dependent manner. J Biol Chem. 1997, 272: 11663-11669. 10.1074/jbc.272.17.11663.
Article
CAS
PubMed
Google Scholar
Honda R, Ohba Y, Yasuda H: 14-3-3 protein binds to the carboxyl half of mouse wee1 kinase. Biochem Biophys Res Commun. 1997, 230: 262-265. 10.1006/bbrc.1996.5933.
Article
CAS
PubMed
Google Scholar
Zha J, Harada H, Yang E, Jockel J, Korsmeyer SJ: Serine phosphorylation of death agonist BAD in response to survival factor results in binding to 14-3-3 not BCL-X. Cell. 1996, 87: 619-628. 10.1016/S0092-8674(00)81382-3.
Article
CAS
PubMed
Google Scholar
Yang J, Winkler K, Yoshida M, Kornbluth S: Maintenance of G2arrest in the Xenopus oocyte: a role for 14- 3-3-mediated inhibition of Cdc25 nuclear import. EMBO J. 1999, 18: 2174-2183. 10.1093/emboj/18.8.2174.
Article
CAS
PubMed
PubMed Central
Google Scholar
Aitken A: 14-3-3 and its possible role in co-ordinating multiple signaling pathway. Trends Cell Biol. 1996, 6: 341-347. 10.1016/0962-8924(96)10029-5.
Article
CAS
PubMed
Google Scholar
Roy S, McPherson RA, Apolloni A, Yan J, Lane A, Clyde-Smith J, Hancock JF: 14-3-3 facilitates Ras-dependent Raf-1 activation in vitro and in vivo. Mol Cell Biol. 1998, 18: 3947-3955.
Article
CAS
PubMed
PubMed Central
Google Scholar
Kosaki A, Yamada K, Suga J, Otaka A, Kuzuya H: 14-3-3 protein associates with insulin receptor substrate 1 and decreases insulin-stimulated phosphatidylinositol 3-kinase activity in 3T3L1 adipocytes. J Biol Chem. 1998, 273: 940-944. 10.1074/jbc.273.2.940.
Article
CAS
PubMed
Google Scholar
Braselmann S, McCormick F: Bcr and Raf form a complex in vivo via 14-3-3 proteins. EMBO J. 1995, 14: 4839-4848.
CAS
PubMed
PubMed Central
Google Scholar
van Heusden GP: 14-3-3 proteins: regulators of numerous eukaryotic proteins. IUBMB Life. 2005, 57: 623-629.
Article
CAS
PubMed
Google Scholar